Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Finished Goods: 2019-2021

  • CureVac N.V's Finished Goods was N/A to $24.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $24.9 million, marking a year-over-year change of. This contributed to the annual value of $883,487 for FY2020, which is 3890.86% up from last year.
  • Per CureVac N.V's latest filing, its Finished Goods stood at $24.9 million for Q3 2021, which was up 2,713.65% from $883,487 recorded in Q4 2020.
  • In the past 5 years, CureVac N.V's Finished Goods registered a high of $24.9 million during Q3 2021, and its lowest value of $22,138 during Q4 2019.
  • In the last 3 years, CureVac N.V's Finished Goods had a median value of $883,487 in 2020 and averaged $8.6 million.
  • Data for CureVac N.V's Finished Goods shows a peak YoY soared of 3,890.86% (in 2020) over the last 5 years.
  • Quarterly analysis of 3 years shows CureVac N.V's Finished Goods stood at $22,138 in 2019, then skyrocketed by 3,890.86% to $883,487 in 2020, then reached $24.9 million in 2021.
  • Its Finished Goods stands at $24.9 million for Q3 2021, versus $883,487 for Q4 2020 and $22,138 for Q4 2019.